Company profile: Synchrogenix
1.1 - Company Overview
Company description
- Provider of strategic regulatory writing and related services for the pharmaceutical and biotech industry, offering regulatory strategy, consulting, and submissions support from preclinical to post-marketing; eCTD publishing and management; medical writing and scientific communications; clinical data transparency, anonymization and redaction; document quality and management; and GlobalSubmit eCTD software.
Products and services
- Document Quality & Management: Delivers quality control, formatting, and publishing of regulatory documents to meet agency requirements, via agency‑compliant management across document preparation and release
- Regulatory Operations Services: Produces eCTD publishing and management to ensure compliance with global regulatory submission standards, supplying global‑compliant handling of electronic submissions
- Regulatory Science: Architects regulatory strategy, consulting, and submissions support for drug and device development from preclinical through post‑marketing, delivering full‑lifecycle guidance and execution
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Synchrogenix
TransCure BioServices
HQ: Switzerland
Website
- Description: Provider of predictive preclinical R&D services via fee-for-service access to humanized mouse platforms, including CD34+ humanized immune system, humanized liver, immuno-oncology, IBD, inflammatory disorder, and infectious disease (HIV, HBV) models, used to profile new drugs and assess efficacy/toxicity, drug-drug interactions, immunotherapies, and antivirals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TransCure BioServices company profile →
Astoriom
HQ: United Kingdom
Website
- Description: Provider of ICH-compliant sample stability and biorepository storage solutions for pharmaceutical and medical device sectors, offering controlled temperature/humidity from -196°C to +60°C with cGMP compliance, packaging and transport; custom storage design; equipment service and validation; disaster protection and recovery; and inventory intelligence with real-time reporting and audit trails.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Astoriom company profile →
The Medicine Maker
HQ: United Kingdom
Website
- Description: Provider of a publication for persons involved in the development and manufacture of pharmaceuticals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full The Medicine Maker company profile →
Catalent
HQ: United States
Website
- Description: Provider of advanced drug delivery technologies and outsourced development, manufacturing, and packaging services for the pharmaceutical, biotechnology, and consumer health industries worldwide. Includes Development & Clinical Services; Oral, Sterile, and Packaging technologies; ProteoSuite Oral; Softgel technologies; inhalation development & analytical; biologics development with GMP analytics; clinical supply services; consumer health products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Catalent company profile →
Synerlab
HQ: France
Website
- Description: Provider of contract development and manufacturing for medicinal products (human and veterinary), medical devices and food supplements, from product development to manufacturing and packaging across solid and semi-solid forms and non-sterile/sterile liquids. Services include formulation, galenics, analytics, clinical batches (phase 1–3), production of oral solids, non-sterile monodose, sterile multidose (nasal/eye/ear drops), and freeze drying, including biomolecular drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synerlab company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Synchrogenix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Synchrogenix
2.2 - Growth funds investing in similar companies to Synchrogenix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Synchrogenix
4.2 - Public trading comparable groups for Synchrogenix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →